August 12 2003  


 

CONCORD, Ca.,   August 7, 2003 – Siemens Medical Solutions announced today that an agreement has been signed with Nucletron B.V. to offer Nucletron Simulix simulators to Siemens oncology customers worldwide.  Under this agreement, Siemens Oncology Care now offers a new line of world-class simulation solutions for radiation therapy.


“Siemens Medical is the leading provider of solutions for imaging and therapy, and this partnership with Nucletron enhances our ability to provide our customers with a more complete solution, with continued excellence in simulation for radiation therapy,” said Ajit Singh, Ph.D., president of Siemens Oncology Care. “Last year we launched our CT based simulation solutions with Siemens COHERENCE Dosimetrist. This year we are partnering with Nucletron to better provide our customers with a variety of configurations and options for conventional simulation, as well.”


“Our partnership with Siemens Medical is an excellent opportunity to improve access for the radiotherapy community to our wide range of simulation solutions,” said Rudolf Scholte, Ph.D., managing director of Nucletron B.V.  “Our renowned Simulix simulator products have established our leading position around the world with over 1000 installed systems, and we continue to invest in technology like the digital flat panel detector, incorporated in our new Simulix EVOLUTION™ simulator. Clearly the addition of the Siemens network to our current relationships will give us significant access to all sectors of the market."


Nucletron specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment, with particular expertise in brachytherapy, treatment planning, information management and simulation.


The company has 20 offices worldwide, including its corporate headquarters in The Netherlands. Nucletron® B.V. is a subsidiary of Delft Instruments N.V. (http://www.delftinstruments.com/).  Delft Instruments employs approximately 1,200 people, is listed on Euronext Amsterdam and is included in the NextEconomy segment. The company reported net profit of EUR 10.9 million on turnover of EUR 194 million in 2002. For more information on Nucletron®, please visit: www.nucletron.com.


Siemens Medical Solutions of Siemens AG (NYSE: SI) with headquarters in Malvern, Pennsylvania and Erlangen, Germany, is one of the largest suppliers to the healthcare industry in the world.  The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes.  From imaging systems for diagnosis, to therapy equipment for treatment, to patient monitors to hearing instruments and beyond, Siemens innovations contribute to the health and well-being of people across the globe, while improving operational efficiencies and optimizing workflow in hospitals, clinics, home health agencies, and doctors' offices.  Employing approximately 31,000 people worldwide and operating in more than 120 countries, Siemens Medical Solutions reported sales of 7.6 billion EUR, orders of 8.4 billion EUR and group profit of 1 billion EUR for fiscal 2002. More information can be obtained by visiting www.usa.siemens.com/medical